Newsbot

Should You Invest in Bitcoin Now?

Bitcoin has broken away from the NASDAQ and is now being adopting by public companies and entire countries... including the U.S. As tariff tensions shake traditional markets, Andrew Rocco reveals Bitcoins impressive relative strength and how you can start positioning yourself now.

Core inflation in Japans capital sharply accelerates in April

Core consumer prices in Japans capital rose 3.4% in April from a year earlier, data showed on Friday, accelerating for the second straight month and making the central banks task of balancing risks from higher U.S. tariffs and rising prices more challenging.

Alphabet’s Profit Gets $8 Billion Boost From SpaceX Investment

Alphabet Inc. said its first-quarter profit was boosted by $8 billion in unrealized gains from an investment in a private company. That company is Elon Musk’s Space Exploration Technologies Corp., according to a person familiar with the matter.

Congress Republicans seek $27 billion for Golden Dome in Trump tax bill: Reuters

Republicans in the U.S. Congress plan to introduce a sweeping $150 billion defense package that will give an initial $27 billion boost to President Donald Trumps controversial Golden Dome missile defense shield and bolstering shipbuilding, according to a document and a congressional aide.

Newmont (NEM) Q1 2025 Earnings Call

Image source: The Motley Fool. DATEThursday, Apr 24, 2025CALL PARTICIPANTSTom Palmer: President and Chief Executive OfficerKaryn Ovelmen: Chief Financial OfficerNatascha Viljoen: Chief Operating OfficerNeed a quote from one of our analysts? Email pr@fool.comGold Production: 1,500,000 ounces in Q1, on track with full-year guidance.Copper Production: 35,000 tonnes in Q1, aligning with expectations.Free Cash Flow: $1.2 billion, setting a record for Newmont in Q1 2025.Adjusted EBITDA: $2.6 billi...

Why NovoCure Stock Leaped 4% Higher Today

Thursday morning NovoCure (NASDAQ: NVCR) published its first set of quarterly results for 2025, and they pleased more than a few investors. With that tailwind, the biotechs stock price rose in excess of 4%, easily topping the slightly over 2% increase of the S&P 500 index. A double beat for the inaugural quarter For the first quarter, NovoCure recorded net revenue that was just shy of $155 million. That was a nearly 12% improvement over the same period of 2024. Compounding that, the biotech man...

Bel Fuse (BELFB) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Bel Fuse (BELFB) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.